Federal Register Notice: FDA is making available a guidance for industry entitled Exposure-Response Relationships--Study Design, Data Analysis, and Regulatory Applications. The guidance provides recommendations for sponsors of investigational new drug applications and applicants submitting new drug applications or biologics license applications on the use of exposure-response information in the development of drugs, including therapeutic biologics. To download the guidance, click here. To view this notice, click here.
